HTA116 Cost-Effectiveness of Nirmatrelvir/Ritonavir for the Treatment of Outpatient Sars-Cov-2 in Adult Patients at Risk for Developing Severe Disease in Greece

The objective of this cost effectiveness analysis is to assess the health and economic impact, associated with the introduction of nirmatrelvir/ritonavir as an antiviral treatment for SARS-CoV-2 for adult patients in Greece who do not require supplemental oxygen and who are at increased risk of developing severe disease.

Source: Value in Health - December 1, 2023 Category: International Medicine & Public Health Authors: M. Kalogeropoulou, M. Barmpouni, V. Grammelis, A. Rousakis, A. Livieratos, D. Paraskevis, O. Zisimopoulou Source Type: research